Matthew Vonesch

VP, Xeno And Regenerative Medicine Operations at United Therapeutics Corporation in Durham, North Carolina, United States

Verified profile m***@unither.com
Job Title
VP, Xeno And Regenerative Medicine Operations
Company
United Therapeutics Corporation
Location
Durham, North Carolina, United States
Seniority
Vp
Industry
Pharmaceuticals
Company Size
1,300 employees
Work Email
m***@unither.com
Direct Phone
(410) ***-****
Matthew's full work email still locked
Reveal Matthew's verified work email & direct phone - free

Free account. Verified against live company records.

You'll unlock:
  • Matthew's full verified work email
  • Direct phone number
  • LinkedIn and full company profile

Matthew Vonesch is the VP, Xeno And Regenerative Medicine Operations at United Therapeutics Corporation based in Durham, North Carolina, United States.

Colleagues at United Therapeutics Corporation

Other verified contacts at United Therapeutics Corporation.

Other people named Matthew Vonesch

Different professionals who share this name.

Frequently asked

What is Matthew Vonesch's email address?

Matthew Vonesch's work email follows the pattern m***@unither.com. Reveal it free.

What does Matthew Vonesch do?

Matthew Vonesch is the VP, Xeno And Regenerative Medicine Operations at United Therapeutics Corporation.

Where is Matthew Vonesch based?

Durham, North Carolina, United States.

Who is the VP, Xeno And Regenerative Medicine Operations at United Therapeutics Corporation?

Matthew Vonesch.

Get Matthew Vonesch's verified contact details

Reveal the full work email, direct phone and more. Free to start.

Try ScraperCity Free →
Run an agency? If you look up leads like this to sell your services, I coach agency owners on getting clients. You get 4 coaching calls a week, my courses and a private community. Cancel anytime. It is $597 a month if you join by Dec 31; new members pay $797 from Jan 1. - Alex Berman See Galadon Gold

Not ready yet? Leave your email and we'll send you the details, plus one reminder before the price changes on January 1.